SCHEMBL8940653

SCHEMBL8940653

CCOc1cc(OC(F)(F)F)ccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
ABL1 P00519 1/20 0.46
ABCB1 P08183 1/20 0.46
BCR P11274 1/20 0.46
TOP2A P11388 1/20 0.43
S1PR1 P21453 1/20 0.41
KDM4E B2RXH2 5/20 0.41
HPGD P15428 2/20 0.40
TSHR P16473 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
ALPI P09923 1/20 0.40
ALPG P10696 1/20 0.40
APP P05067 1/20 0.40
POLB P06746 2/20 0.40
GAA P10253 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8940652 0.87 L3MBTL1 (0.47) ALDH1A1MEN1KMT2AL3MBTL1KDM4E
SCHEMBL2097133 0.82 APP (0.49) MEN1KMT2AL3MBTL1APPMAPT
SCHEMBL8386278 0.82 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AL3MBTL1ABL1
SCHEMBL13700996 0.81 L3MBTL1 (0.44) L3MBTL1S1PR1KDM4EPOLB
SCHEMBL365669 0.81 GCGR (0.52) ALDH1A1MEN1KMT2AABL1HPGD
SCHEMBL22208481 0.81 L3MBTL1 (0.44) L3MBTL1S1PR1KDM4ETSHRPOLB
SCHEMBL31697241 0.81 L3MBTL1 (0.44) L3MBTL1S1PR1KDM4ETSHRPOLB
SCHEMBL22208649 0.80 S1PR1 (0.43) MEN1KMT2AL3MBTL1S1PR1KDM4E
SCHEMBL20652692 0.80 KDM4E (0.51) L3MBTL1S1PR1KDM4ETSHRGAA
SCHEMBL31697316 0.80 S1PR1 (0.43) MEN1KMT2AL3MBTL1S1PR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441703-B2 Carboxamides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-10-14 US disclosed
US-20230062053-A1 CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2023-03-02 US disclosed
US-20230062053-A1 CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2023-03-02 US disclosed
WO-2020146682-A1 CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-07-16 WO disclosed
WO-2020146682-A1 CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-07-16 WO disclosed
EP-0700384-A1 PROCESS FOR PREPARING AND RESOLVING 2-PHENYL-3-AMINOPIPERIDINE PFIZER (US) 1996-03-13 EP disclosed
WO-1994027966-A1 PROCESS FOR PREPARING AND RESOLVING 2-PHENYL-3-AMINOPIPERIDINE PFIZER INC. (US) 1994-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12441703-B2 Carboxamides as modulators of sodium channels TRPV1, SCN2A, SCN10A ALDH1A1 2665/4885MEN1 3203/4885KMT2A 1313/4885
US-20230062053-A1 CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS TRPV1, SCN2A, SCN10A ALDH1A1 2665/4885MEN1 3203/4885KMT2A 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.